Document and Entity Information
Document and Entity Information | May 15, 2023 |
Document and Entity Information [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 15, 2023 |
Entity File Number | 001-36845 |
Entity Registrant Name | Bellerophon Therapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-3116175 |
Entity Address, Address Line One | 20 Independence Boulevard, Suite 402 |
Entity Address, City or Town | Warren |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 07059 |
City Area Code | 908 |
Local Phone Number | 574-4770 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.01 par value per share |
Trading Symbol | BLPH |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001600132 |
Amendment Flag | false |